UPDATE 1-Shire wins U.S. approval for long-acting ADHD drug By: Reuters: Company News June 21, 2017 at 04:32 AM EDT * Shares up 1.5 percent in London trading (Adds sales forecasts, shares, reaction) Read More >> Related Stocks: Aevi Genomic Medicine Arcturus Therapeutics Holdings Inc Neos Therapeutics